The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of ...
Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results